MedPath

Effects of Genetic Variations in the Response to Brazil Nut Supplementation

Not Applicable
Completed
Conditions
Dietary Supplements
Interventions
Dietary Supplement: Brazil nut
Registration Number
NCT03111355
Lead Sponsor
University of Sao Paulo
Brief Summary

This study investigates the effect of genetic variations after supplementation with Brazil nuts in healthy Brazilians. Briefly, all the participants will consume one nut a day for 2 months and will stop the intake for more 2 months. Five blood sampling collection will be performed in one month interval, starting at baseline and ending at 2 months without intervention.

Detailed Description

Brazil nuts are the richest source of selenium in nature, a micronutrient that has essential functions in human physiology.

Selenium status can be measured by the quantification of biomarkers in the blood. Previous studies have shown that genetic polymorphisms can affect Se status and modulate risk for chronic diseases. In this study, five biomarkers will be quantified in the blood, before and after supplementation with Brazil nuts. The genetic variants will be used to stratify the biomarkers and multivariate linear regressions will be used to explore the influence of the polymorphisms on concentrations of the biomarkers .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • age between 20 and 60 years; not taking vitamin and minerals supplements, not taking antiinflammatory, not having chronic diseases
Read More
Exclusion Criteria
  • athletes, excessive alcohol consumption, being obese, having cancer, cardiovascular disease, diabetes and hypo or hyperthyroidism
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Brazil Nut supplementationBrazil nutConsumption of one Brazil nut a day for 2 months followed by 2 months without intervention
Primary Outcome Measures
NameTimeMethod
change in Plasma Se concentrations4 weeks

measured by ICP-MS (ug/L)

change in Plasma Glutathione Peroxidase 3 activity4 weeks

measured by kinetic assay in a spectrometer (U/L)

change in Erythrocyte Glutathione Peroxidase 1 activity4 weeks

measured by kinetic assay in an automatic spectrometer (U/gHb)

change in Erythrocyte Se concentrations4 weeks

measured by ICP-MS (ug/L)

change in Plasma Selenoprotein P concentrations4 weeks

measured by ELISA (mg/dL)

Secondary Outcome Measures
NameTimeMethod
change in total cholesterol concentration in serum4 weeks

measured in an automatic spectrometer (mg/dL)

change in HDL concentration in serum4 weeks

measured in an automatic spectrometer (mg/dL)

change in LDL concentration in serum4 weeks

measured in an automatic spectrometer (mg/dL)

change in protein-c reactive concentration in serum4 weeks

measured in an automatic spectrometer (mg/dL)

change in Plasma MDA concentrations (malondialdehyde)4 weeks

measured in an automatic spectrometer (mg/dL)

change in tryglicerides concentration in serum4 weeks

measured in an automatic spectrometer (mg/dL)

© Copyright 2025. All Rights Reserved by MedPath